EMD 5.88% 3.2¢ emyria limited

Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 75 Posts.
    lightbulb Created with Sketch. 14
    Exciting news. it’s almost like they have been on the HotCopper boards to see what share holders want. And we want news regarding progress of trials and results.

    Still room on this rocket before it takes off.

    I might have to look under the couch for some pennies.

    I enjoyed reading the comparison table between the CBD oils and RX5.

    Clearly demonstrates the companies beliefs in the product and the gap in the current market that this product fills.

    bring on the next 12 months I say.

    as always DYOR
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
-0.002(5.88%)
Mkt cap ! $13.29M
Open High Low Value Volume
3.5¢ 3.5¢ 3.2¢ $13.66K 397.5K

Buyers (Bids)

No. Vol. Price($)
2 177108 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 75371 1
View Market Depth
Last trade - 15.54pm 13/11/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.